CQUniversity
Browse

File(s) not publicly available

Genetically modified tumour cells expressing IL-15 and IL-15Ralpha as an in situ cancer vaccination platform

journal contribution
posted on 2018-12-05, 00:00 authored by Jason SteelJason Steel, Charmaine Ramlogan-SteelCharmaine Ramlogan-Steel, JC Morris
Interleukin-15 (IL-15) is a pleiotropic cytokinewith the ability to increase the effectiveness ofvaccines through enhancement of both innateand adaptive immune responses.

Funding

Other

History

Volume

17

Issue

8-9

Start Page

186

End Page

187

Number of Pages

2

ISSN

1099-498X

Publisher

Wiley

Full Text URL

Peer Reviewed

  • Yes

Open Access

  • Yes

External Author Affiliations

University of Queensland; University of Cincinnati

Era Eligible

  • No

Journal

Journal of Gene Medicine

Usage metrics

    CQUniversity

    Categories

    Keywords

    Interleukin-15 (IL-15)Tumour cellsCancer vaccination platformCancer Therapy (excl. Chemotherapy and Radiation Therapy)

    Licence

    CQUniversity Open Access 1.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC